BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21078522)

  • 1. Common genetic variation within IGFI, IGFII, IGFBP-1, and IGFBP-3 and endometrial cancer risk.
    McGrath M; Lee IM; Buring J; De Vivo I
    Gynecol Oncol; 2011 Feb; 120(2):174-8. PubMed ID: 21078522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3).
    Patel AV; Cheng I; Canzian F; Le Marchand L; Thun MJ; Berg CD; Buring J; Calle EE; Chanock S; Clavel-Chapelon F; Cox DG; Dorronsoro M; Dossus L; Haiman CA; Hankinson SE; Henderson BE; Hoover R; Hunter DJ; Kaaks R; Kolonel LN; Kraft P; Linseisen J; Lund E; Manjer J; McCarty C; Peeters PH; Pike MC; Pollak M; Riboli E; Stram DO; Tjonneland A; Travis RC; Trichopoulos D; Tumino R; Yeager M; Ziegler RG; Feigelson HS;
    PLoS One; 2008 Jul; 3(7):e2578. PubMed ID: 18596909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variants in IGF-I, IGF-II, IGFBP-3, and adiponectin genes and colon cancer risk in African Americans and Whites.
    Keku TO; Vidal A; Oliver S; Hoyo C; Hall IJ; Omofoye O; McDoom M; Worley K; Galanko J; Sandler RS; Millikan R
    Cancer Causes Control; 2012 Jul; 23(7):1127-38. PubMed ID: 22565227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common genetic variation in IGF1, IGFBP1 and IGFBP3 and ovarian cancer risk.
    Terry KL; Tworoger SS; Gates MA; Cramer DW; Hankinson SE
    Carcinogenesis; 2009 Dec; 30(12):2042-6. PubMed ID: 19858071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of insulin-like growth factor (IGF) and IGF-binding protein (IGFBP) genes in the human placenta and membranes: evidence for IGF-IGFBP interactions at the feto-maternal interface.
    Han VK; Bassett N; Walton J; Challis JR
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2680-93. PubMed ID: 8675597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microsatellite polymorphism in the P1 promoter region of the IGF‑1 gene is associated with endometrial cancer.
    Kwasniewski W; Gozdzicka-Jozefiak A; Wolun-Cholewa M; Polak G; Sierocinska-Sawa J; Kwasniewska A; Kotarski J
    Mol Med Rep; 2016 Jun; 13(6):4950-8. PubMed ID: 27121258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The IGF system in the neonatal ovine uterus.
    Hayashi K; Carpenter KD; Welsh TH; Burghardt RC; Spicer LJ; Spencer TE
    Reproduction; 2005 Mar; 129(3):337-47. PubMed ID: 15749960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factors and insulin-like growth factor binding proteins in the endometrium. Effect of intrauterine levonorgestrel delivery.
    Rutanen EM
    Hum Reprod; 2000 Aug; 15 Suppl 3():173-81. PubMed ID: 11041233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysis.
    Watts EL; Perez-Cornago A; Fensom GK; Smith-Byrne K; Noor U; Andrews CD; Gunter MJ; Holmes MV; Martin RM; Tsilidis KK; Albanes D; Barricarte A; Bueno-de-Mesquita HB; Cohn BA; Deschasaux-Tanguy M; Dimou NL; Ferrucci L; Flicker L; Freedman ND; Giles GG; Giovannucci EL; Haiman CA; Hankey GJ; Holly JMP; Huang J; Huang WY; Hurwitz LM; Kaaks R; Kubo T; Le Marchand L; MacInnis RJ; Männistö S; Metter EJ; Mikami K; Mucci LA; Olsen AW; Ozasa K; Palli D; Penney KL; Platz EA; Pollak MN; Roobol MJ; Schaefer CA; Schenk JM; Stattin P; Tamakoshi A; Thysell E; Tsai CJ; Touvier M; Van Den Eeden SK; Weiderpass E; Weinstein SJ; Wilkens LR; Yeap BB; ; Allen NE; Key TJ; Travis RC
    Int J Epidemiol; 2023 Feb; 52(1):71-86. PubMed ID: 35726641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians.
    Schumacher FR; Cheng I; Freedman ML; Mucci L; Allen NE; Pollak MN; Hayes RB; Stram DO; Canzian F; Henderson BE; Hunter DJ; Virtamo J; Manjer J; Gaziano JM; Kolonel LN; Tjønneland A; Albanes D; Calle EE; Giovannucci E; Crawford ED; Haiman CA; Kraft P; Willett WC; Thun MJ; Le Marchand L; Kaaks R; Feigelson HS; Bueno-de-Mesquita HB; Palli D; Riboli E; Lund E; Amiano P; Andriole G; Dunning AM; Trichopoulos D; Stampfer MJ; Key TJ; Ma J
    Hum Mol Genet; 2010 Aug; 19(15):3089-101. PubMed ID: 20484221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression of the IGF system in the bovine uterus throughout the oestrous cycle and early pregnancy.
    Robinson RS; Mann GE; Gadd TS; Lamming GE; Wathes DC
    J Endocrinol; 2000 May; 165(2):231-43. PubMed ID: 10810287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic determinants of circulating insulin-like growth factor (IGF)-I, IGF binding protein (BP)-1, and IGFBP-3 levels in a multiethnic population.
    Cheng I; DeLellis Henderson K; Haiman CA; Kolonel LN; Henderson BE; Freedman ML; Le Marchand L
    J Clin Endocrinol Metab; 2007 Sep; 92(9):3660-6. PubMed ID: 17566087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ontogeny of IGFs and IGFBPs mRNA levels and tissue concentrations in liver, kidney and skeletal muscle of pig.
    Peng M; Pelletier G; Palin MF; Véronneau S; LeBel D; Abribat T
    Growth Dev Aging; 1996; 60(3-4):171-87. PubMed ID: 9007568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation in plasma insulin-like growth factor-1 and insulin-like growth factor binding protein-3: genetic factors.
    Morimoto LM; Newcomb PA; White E; Bigler J; Potter JD
    Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1394-401. PubMed ID: 15941947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factors, insulin-like growth factor-binding proteins, and endometrial cancer in postmenopausal women: results from a U.S. case-control study.
    Lacey JV; Potischman N; Madigan MP; Berman ML; Mortel R; Twiggs LB; Barrett RJ; Wilbanks GD; Lurain JR; Fillmore CM; Sherman ME; Brinton LA
    Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):607-12. PubMed ID: 15066926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factors in endometrial function.
    Rutanen EM
    Gynecol Endocrinol; 1998 Dec; 12(6):399-406. PubMed ID: 10065165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin/IGF and sex hormone axes in human endometrium and associations with endometrial cancer risk factors.
    Merritt MA; Strickler HD; Einstein MH; Yang HP; Sherman ME; Wentzensen N; Brouwer-Visser J; Cossio MJ; Whitney KD; Yu H; Gunter MJ; Huang GS
    Cancer Causes Control; 2016 Jun; 27(6):737-48. PubMed ID: 27125830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endometrial expression of mRNA encoding insulin-like growth factors I and II and IGF-binding proteins 1 and 2 in early pregnant ewes.
    Cann CH; Fairclough RJ; Sutton R; Gow CB
    J Reprod Fertil; 1997 Sep; 111(1):7-13. PubMed ID: 9370961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor regulation of human endometrial stromal cell function: coordinate effects on insulin-like growth factor binding protein-1, cell proliferation and prolactin secretion.
    Irwin JC; de las Fuentes L; Dsupin BA; Giudice LC
    Regul Pept; 1993 Oct; 48(1-2):165-77. PubMed ID: 7505463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressed expression of insulin-like growth factor binding protein-1 mRNA in the endometrium: a molecular mechanism associating endometrial cancer with its risk factors.
    Rutanen EM; Nyman T; Lehtovirta P; Ammälä M; Pekonen F
    Int J Cancer; 1994 Nov; 59(3):307-12. PubMed ID: 7523316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.